Cardiovascular medication :: Consumers survey results of for 1 quarter of 2011

Consumers survey results of for 1 quarter of 2011 in category

Circulatory system / Cardiovascular medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Validol (Farmak)	34.38%	5

2.	3	Нітрогліцерин (Технолог)	31.25%	4.55

3.	2	Валідол-Дарниця (Darnitsa)	29.69%	4.32

4.	2	Корвалтаб (Фарма Старт)	25.00%	3.64

5.	4	Корвалмент (Київський вітамінний завод)	23.44%	3.41

5.		Пумпан (Perrigo)	23.44%	3.41

7.	2	Аспаркам (Arterium Corporation)	21.88%	3.18

8.		Валідол (Лубнифарм)	15.63%	2.27

9.	5	Вітрум кардіо / Вітрум кардіо Омега-3 (Такеда)	14.06%	2.05

10.	6	Aspirin cardio (Bayer)	12.50%	1.82

11.	5	Аспекард (Стиролбіофарм)	9.38%	1.36

11.	6	Кратал (Борщагівський ХФЗ)	9.38%	1.36

11.	1	Трикардин (Ternopharm)	9.38%	1.36

14.	4	АТФ-Лонг (Борщагівський ХФЗ)	7.81%	1.14

14.		Глоду настоянка (Ternopharm)	7.81%	1.14

14.	4	Краплі Зеленіна (Фітофарм)	7.81%	1.14

17.	5	Панангін (Gedeon Richter)	6.25%	0.91

18.	6	Глоду настоянка (Лубнифарм)	4.69%	0.68

18.	7	Кардіплант (Schwabe)	4.69%	0.68

18.	6	Кралонін (Heel)	4.69%	0.68

18.	6	Ритмокор (Фаркос)	4.69%	0.68

–.	8	~~Гербіон серцеві краплі (KRKA)~~	~~4.69%~~	~~0.68~~

22.	6	Кардио-гран (Національна гомеопатична спілка)	3.13%	0.45

22.	~	Хомвіотензин (Homviora Arzneimittel)	3.13%	0.45

24.	7	АТФ-Лонг (Фаркос)	1.56%	0.23

24.	~	Екорін (USV Limited)	1.56%	0.23

24.		Кверцетин (Борщагівський ХФЗ)	1.56%	0.23

24.	~	Хомвіокорин-N (Homviora Arzneimittel)	1.56%	0.23

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2011, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.